We earn a commission from brands on this page, which impacts their display. Advertising disclosure

Explainer

Does insurance cover GLP-1 weight-loss medications?

By the TreatmentMD editorial team

Updated 7 min read

A laughing man with a beard in a white T-shirt

Key takeaways

  • Coverage for weight loss depends mostly on your plan, and Medicare now covers some GLP-1s for $50 a month for people who qualify.KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sourcesCenters for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
  • Plans that cover them usually ask for a BMI of 30, or 27 with a weight-related condition, and an approval your clinician requests.Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sourcesNovo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources
  • If your plan says no, you still have good options, from cash prices to online programs that don't need insurance at all.

By the TreatmentMD editorial team

Insurance is often one of the first things people wonder about with a GLP-1. Fair question, since these medicines aren't cheap.

The short answer is sometimes. It depends more on your plan than on the medicine. And you can find out where you stand before you start.

Here's how coverage works, and what to do whichever answer you get.

01The short answer

Does insurance cover GLP-1s for weight loss?

Sometimes. Each plan decides whether it pays for weight-loss medicines at all. With a plan through work, that's usually your employer's call. So two people with the same insurer can get different answers.UnitedHealthcareSourceUnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026.Open the source All sources

In 2025, about 1 in 5 employers with 200 or more workers covered GLP-1s for weight loss. Among the biggest, with 5,000 workers or more, it was 43%.KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources

Here's how it usually looks, by type of coverage:

For weight loss?Good to know
A plan through workSometimesYour employer decidesUnitedHealthcareSourceUnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026.Open the source All sources
A Marketplace planRarelyA few plans include themKFFSourceKFF. Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans. June 12, 2024.Open the source All sources
MedicareYes, if you qualify$50 a month through 2027Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
MedicaidIn some statesEach state decidesKFFSourceKFF. Medicaid Coverage of and Spending on GLP-1s. January 16, 2026.Open the source All sources
TRICAREWith Prime or SelectAfter a prior authorizationExpress Scripts, TRICARE Pharmacy ProgramSourceExpress Scripts, TRICARE Pharmacy Program. Are GLP-1 and weight loss medications covered through the TRICARE pharmacy benefit? Checked October 6, 2026.Open the source All sources
The VAYes, if you qualifyAlongside its MOVE! programU.S. Department of Veterans AffairsSourceU.S. Department of Veterans Affairs. Weight Management: A VA Clinician's Summary (2025). June 2025.Open the source All sources
Checked in October 2026.

02Why it varies

Why does one plan cover it and another doesn't?

Mostly, it comes down to cost. These medicines are popular and pricey, so each plan weighs them against everything else it pays for. Many large employers that cover them told KFF that more people used them than expected.KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources

Medicare and Medicaid have their own rules. Medicare drug plans aren't allowed to pay for weight-loss medicines, which is why Medicare set up its own program in 2026. For Medicaid, covering them for weight loss is each state's choice.U.S. Government Publishing OfficeSourceU.S. Code, Title 42, sections 1395w-102(e)(2) and 1396r-8(d)(2): weight-loss drugs in Medicare Part D and Medicaid.Open the source All sources

Coverage also follows what each medicine is approved for, and some do more than weight loss. Wegovy® is approved to help protect the heart in adults with heart disease. Zepbound® is approved to treat moderate to severe sleep apnea in adults with obesity.U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sources

So a plan that won't cover them for weight loss may still cover them for those. If either fits you, it's worth mentioning to your clinician.Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources

And plans change, often once a year, sometimes in your favor. On October 1, 2026, for example, Zepbound® was added back to some of CVS Caremark's drug lists.Eli Lilly and CompanySourceLilly. Zepbound® savings and insurance options. Checked October 6, 2026.Open the source All sources

03Qualifying

What do plans usually ask for?

Plans that cover GLP-1s for weight loss tend to follow the medicine's label. That usually means a BMI of 30 or more, or 27 or more with a weight-related condition, like high blood pressure.U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sourcesCigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sources

Some ask for a little more, like a few months of diet and activity changes first, or joining a lifestyle program. Your clinician notes these on the form.Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sourcesKFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources

Most plans also need a prior authorization. That's a request your clinician sends, asking your plan to approve the medicine before it pays.Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources

It can take up to 10 business days, so ask your clinician's office to send it right away.Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources

An approval lasts from 30 days to more than a year, depending on your plan.Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources At renewal, plans usually want to see that it's working. Cigna's and UnitedHealthcare's policies, for example, look for at least 5% of your starting weight lost.Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sourcesUnitedHealthcareSourceUnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026.Open the source All sources

If you've already started, there's good news. Cigna's policy and Medicare's program both go by your BMI from before you began. So the weight you lose doesn't count against you.Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sourcesCenters for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sources

04Medicare

Does Medicare cover GLP-1s for weight loss?

A smiling man with sandy, graying hair in a white T-shirt

Yes, if you qualify. Since July 1, 2026, a temporary program called the Medicare GLP-1 Bridge has covered some GLP-1s for $50 a month.Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources

It covers the Wegovy® shot and pill, Foundayo™ and the Zepbound® KwikPen, and it runs through December 31, 2027.Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources

You'll need Medicare drug coverage (Part D), plus one of these from before you started a GLP-1:Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sourcesCenters for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sources

  1. A BMI of 35 or more

    No other condition needed.

  2. A BMI of 30 or more

    With certain types of heart failure, high blood pressure that's hard to control, or chronic kidney disease (stage 3a or higher).

  3. A BMI of 27 or more

    With prediabetes, or if you've had a heart attack, a stroke or blocked arteries in your legs or arms.

Have type 2 diabetes, moderate to severe sleep apnea or fatty liver disease? Then you'd go through your own Medicare drug plan instead. It may already cover a GLP-1 for you.Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources

Getting started is simple, and there's nothing to sign up for. Your clinician sends a prescription to your pharmacy, then fills in a form for Medicare's approval when the pharmacy asks.Centers for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sources

Medicare decides within 72 hours and sends you a letter. Then it's $50 a month at the pharmacy, and refills and dose changes don't need a new approval.Centers for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sourcesCenters for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources

05Checking

How do you check your coverage?

A call to your plan, or a look in its app, tells you most of what you need. Have your card handy. Here's what to ask:

  1. Call the number on your card

    Ask if your plan covers the medicine for weight loss, by name: Wegovy®, Zepbound® or Foundayo™. Ask about the shot and the pill too, since they can be covered differently.Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources

  2. Ask about prior authorization

    If your plan needs one, ask for its criteria in writing, so your clinician knows exactly what to send.Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources

  3. Ask what you'd pay

    Ask whether it's a copay (a set amount) or coinsurance (a share of the price), and whether your deductible applies first.Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources

  4. Jot down the answers

    Note who you spoke with and when. It saves time if you need to follow up later.Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. Internal appeals. Checked October 6, 2026.Open the source All sources

  5. Share them with your clinician

    They'll use your plan's criteria to send the prior authorization.Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources

06Paying

What will you pay if you're covered?

If your plan covers it, the maker's savings card can lower your share to as little as $25 a month.Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sourcesEli Lilly and CompanySourceLilly. Zepbound® savings and insurance options. Checked October 6, 2026.Open the source All sources

The cards take off up to $100 a month. So a $60 copay becomes $25, and a $300 one becomes $200.Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sources

They're for private insurance, like a plan through work or one you buy yourself. They can't be used with Medicare, Medicaid, TRICARE or the VA.Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sourcesEli Lilly and CompanySourceLilly. Zepbound® savings and insurance options. Checked October 6, 2026.Open the source All sources

07If it's a no

What if your plan won't cover it?

A man with curly dark hair and a moustache in a white T-shirt

A no from your plan isn't always the final word. First, ask why. Your plan has to tell you, and the reason points to your next step.Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. How to appeal an insurance company decision. Checked October 6, 2026.Open the source All sources

Was it a medical reason, like a missing note or a question about your BMI? Your clinician can resend the request, or appeal with a letter. You have 180 days to appeal.Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. Internal appeals. Checked October 6, 2026.Open the source All sources

If the plan still says no, you can ask for an independent review, and your plan has to accept its decision.Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. External review. Checked October 6, 2026.Open the source All sources

If your plan simply doesn't include weight-loss medicines, that's a benefit choice rather than a medical one. An appeal won't usually change it, but a few other doors are worth trying:Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. External review. Checked October 6, 2026.Open the source All sources

  1. Ask about another use

    If you have heart disease or sleep apnea, ask whether your plan covers Wegovy® or Zepbound® for that.U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sources

  2. Ask your employer

    With a plan through work, your clinician can write to your HR team, asking them to add coverage.Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources

  3. Compare plans at enrollment

    If you can choose a plan for next year, check each one's list of covered drugs before you pick.

08Without insurance

Can you get a GLP-1 without insurance?

Yes. The makers sell their medicines directly, at set cash prices.

The Wegovy® shot is $199 a month for your first two fills, then $349. The Wegovy® pill starts at $149 a month.Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 6, 2026.Open the source All sources

Foundayo™ starts at $149 a month too, and Zepbound® runs from $299 to $449.Eli Lilly and CompanySourceLillyDirect. Foundayo™ (orforglipron) self-pay prices. Checked October 6, 2026.Open the source All sourcesEli Lilly and CompanySourceLillyDirect. Zepbound® (tirzepatide) self-pay prices. Checked October 6, 2026.Open the source All sources

Compounded semaglutide and tirzepatide cost less again. At the programs we rank, semaglutide runs from $49 to $179 a month, and tirzepatide starts at $89. We checked in late September and early October 2026.

Our guide to compounded GLP-1s explains what they are.

Frequently asked questions.

Why does my plan cover Ozempic® but not Wegovy®?

Plans cover each medicine for what it's approved for, and many leave out weight-loss medicines altogether.KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources

Ozempic® is approved for type 2 diabetes and Wegovy® for weight loss.

So a plan can cover one and not the other, even though both are semaglutide.

Mounjaro® and Zepbound® work the same way.U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sources

Does insurance cover compounded GLP-1s?

Usually not.

Plans generally pay for the brand-name medicines, so compounded semaglutide and tirzepatide are paid in cash.

They often cost less than the brands' cash prices.Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0251: Compounded Medications. Effective December 15, 2025.Open the source All sources

Can I use my HSA or FSA?

Usually, yes.

The IRS counts prescribed medicines as medical expenses, so a GLP-1 your clinician prescribes generally qualifies.Internal Revenue ServiceSourceIRS. Publication 502 (2025), Medical and Dental Expenses.Open the source All sources

Several of the programs we rank say their plans are HSA and FSA eligible too.

It's worth checking with your plan's administrator first.

Do online weight-loss programs take insurance?

Some do.

A few help you use your insurance for brand-name medicine, and file the prior authorization for you.

Many others are cash pay, so you don't need insurance at all.

Each of our reviews says how the program handles payment.

The bottom line

Whether insurance covers a GLP-1 comes down to your plan, and a quick call tells you where you stand.

If you're covered, a savings card can trim your share.

If you're not, cash prices and online programs put treatment within reach.

When you're ready, compare programs on our ranking to find one that fits how you want to pay.

By the TreatmentMD editorial team

Medical disclaimerThis content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any weight-loss program or medication. Individual results may vary.

Sources23 sources, and product and safety information
  1. 1KFF. 2025 Employer Health Benefits Survey. October 22, 2025. kff.org
  2. 2Medicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026. medicare.gov
  3. 3Cigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026. cigna.com
  4. 4NovoCare. Check your coverage for Wegovy®. Checked October 6, 2026. novocare.com
  5. 5UnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026. uhcprovider.com
  6. 6KFF. Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans. June 12, 2024. kff.org
  7. 7KFF. Medicaid Coverage of and Spending on GLP-1s. January 16, 2026. kff.org
  8. 8Express Scripts, TRICARE Pharmacy Program. Are GLP-1 and weight loss medications covered through the TRICARE pharmacy benefit? Checked October 6, 2026. express-scripts.com
  9. 9U.S. Department of Veterans Affairs. Weight Management: A VA Clinician's Summary (2025). June 2025. va.gov
  10. 10U.S. Code, Title 42, sections 1395w-102(e)(2) and 1396r-8(d)(2): weight-loss drugs in Medicare Part D and Medicaid. govinfo.gov
  11. 11FDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.
  12. 12Lilly. Zepbound® savings and insurance options. Checked October 6, 2026. lilly.com
  13. 13CMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026. cms.gov
  14. 14NovoCare. Wegovy® Insurance Coverage Guide. September 2026. novocare.com
  15. 15HealthCare.gov. Internal appeals. Checked October 6, 2026. healthcare.gov
  16. 16NovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026. novocare.com
  17. 17HealthCare.gov. How to appeal an insurance company decision. Checked October 6, 2026. healthcare.gov
  18. 18HealthCare.gov. External review. Checked October 6, 2026. healthcare.gov
  19. 19NovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 6, 2026. novocare.com
  20. 20LillyDirect. Foundayo™ (orforglipron) self-pay prices. Checked October 6, 2026. lilly.com
  21. 21LillyDirect. Zepbound® (tirzepatide) self-pay prices. Checked October 6, 2026. lilly.com
  22. 22Cigna Healthcare. Drug Coverage Policy IP0251: Compounded Medications. Effective December 15, 2025. cigna.com
  23. 23IRS. Publication 502 (2025), Medical and Dental Expenses. irs.gov

Product information

  • Zepbound® (tirzepatide) is a prescription-only injectable medication FDA-approved for chronic weight management in adults with obesity, or adults with overweight who have at least one weight-related medical condition. It is also approved for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, and should be used in combination with a reduced-calorie diet and increased physical activity.
  • Ozempic® (semaglutide) is a prescription-only injectable medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals with type 2 diabetes using the medication.
  • Mounjaro® (tirzepatide) is a prescription-only injectable medication FDA-approved for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals using the medication.
  • Wegovy® (semaglutide) is a prescription-only injectable medication FDA-approved for chronic weight management in adults with obesity, or adults with at least one weight-related medical condition, when used alongside a reduced-calorie diet and increased physical activity.
  • All medications require a medical evaluation and prescription from a licensed healthcare provider. Individual results may vary.

Important safety information

  • Compounded semaglutide and tirzepatide are prepared by state-licensed pharmacies and are not FDA approved. The FDA does not review their safety, effectiveness or quality, and clinical trial results for brand-name drugs do not carry over to them.
  • Semaglutide and tirzepatide carry a boxed warning for a risk of thyroid C-cell tumors, based on animal studies, and are not for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2, or who is pregnant. Other warnings include pancreatitis, gallbladder problems, and a higher risk of low blood sugar when combined with insulin or a sulfonylurea. The most common side effects are digestive, such as nausea, vomiting, diarrhea and constipation.
  • This is a high-level summary, not a complete list. A licensed clinician will review your health history to decide whether a GLP-1 medication is right for you.

Our #1 pick

Ready to start? Welludr. is our pick.

The lowest advertised price on our list, with unlimited clinician messaging.